CARECCHIO, MIRYAM
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.714
AS - Asia 2.086
EU - Europa 1.438
SA - Sud America 419
AF - Africa 369
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 16
Totale 9.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.498
SG - Singapore 807
HK - Hong Kong 473
IT - Italia 438
CN - Cina 315
BR - Brasile 295
DE - Germania 140
PL - Polonia 107
VN - Vietnam 88
FR - Francia 87
FI - Finlandia 85
RU - Federazione Russa 62
NL - Olanda 59
GB - Regno Unito 58
SE - Svezia 44
AT - Austria 35
CA - Canada 31
TR - Turchia 30
EC - Ecuador 29
IQ - Iraq 23
ES - Italia 22
BY - Bielorussia 20
ID - Indonesia 20
IN - India 20
MA - Marocco 20
UA - Ucraina 20
AR - Argentina 19
MX - Messico 18
ZA - Sudafrica 18
BE - Belgio 17
CI - Costa d'Avorio 17
JP - Giappone 17
KR - Corea 17
CH - Svizzera 16
JM - Giamaica 16
UZ - Uzbekistan 16
DZ - Algeria 15
JO - Giordania 15
SK - Slovacchia (Repubblica Slovacca) 15
VE - Venezuela 15
IR - Iran 14
IS - Islanda 14
SA - Arabia Saudita 14
AL - Albania 13
BD - Bangladesh 13
MK - Macedonia 13
NI - Nicaragua 13
PH - Filippine 13
PR - Porto Rico 13
TH - Thailandia 13
TN - Tunisia 13
BB - Barbados 12
BF - Burkina Faso 12
DO - Repubblica Dominicana 12
GE - Georgia 12
GT - Guatemala 12
LB - Libano 12
LV - Lettonia 12
ME - Montenegro 12
PK - Pakistan 12
RS - Serbia 12
UY - Uruguay 12
AU - Australia 11
AZ - Azerbaigian 11
BO - Bolivia 11
BW - Botswana 11
EE - Estonia 11
IE - Irlanda 11
KG - Kirghizistan 11
MG - Madagascar 11
MU - Mauritius 11
MW - Malawi 11
NC - Nuova Caledonia 11
PE - Perù 11
RO - Romania 11
CU - Cuba 10
DK - Danimarca 10
LU - Lussemburgo 10
NE - Niger 10
NG - Nigeria 10
PA - Panama 10
RW - Ruanda 10
TJ - Tagikistan 10
YE - Yemen 10
CO - Colombia 9
CW - ???statistics.table.value.countryCode.CW??? 9
CZ - Repubblica Ceca 9
EG - Egitto 9
GM - Gambi 9
HR - Croazia 9
KZ - Kazakistan 9
LA - Repubblica Popolare Democratica del Laos 9
NO - Norvegia 9
PY - Paraguay 9
RE - Reunion 9
SN - Senegal 9
TT - Trinidad e Tobago 9
ZW - Zimbabwe 9
AO - Angola 8
BG - Bulgaria 8
Totale 8.710
Salva come PNG Salva come JPEG
Città #
Fairfield 866
Singapore 515
Ashburn 463
Hong Kong 463
Woodbridge 325
Seattle 315
Cambridge 299
Houston 296
Chandler 246
Wilmington 193
Santa Clara 156
Boardman 108
San Diego 95
Beijing 93
Bytom 92
Ann Arbor 82
Medford 76
Princeton 76
Munich 66
Padova 66
Milan 60
Des Moines 53
Helsinki 46
Los Angeles 38
Dong Ket 34
Hefei 30
New York 27
Nuremberg 24
Rome 24
Roxbury 22
Turku 22
Ho Chi Minh City 21
São Paulo 21
Chicago 19
Abidjan 17
Vienna 17
Buffalo 16
Amman 15
Tashkent 15
London 14
Quito 14
Lappeenranta 13
Minsk 13
Bridgetown 12
Managua 12
Rio de Janeiro 12
Brooklyn 11
Dublin 11
Istanbul 11
Noumea 11
Reykjavik 11
Verona 11
Baku 10
Jinan 10
Kigali 10
Kingston 10
Montevideo 10
Panama City 10
Riga 10
Seoul 10
Tbilisi 10
Dushanbe 9
Gaborone 9
Guatemala City 9
Guayaquil 9
Harare 9
Lima 9
Padua 9
Podgorica 9
Salt Lake City 9
Toronto 9
Warsaw 9
Accra 8
Antananarivo 8
Bangkok 8
Bishkek 8
Boston 8
Dakar 8
Dallas 8
Falkenstein 8
Guangzhou 8
Havana 8
Johannesburg 8
Lilongwe 8
Luanda 8
Montreal 8
Niamey 8
Tallinn 8
Tokyo 8
Treviso 8
Ulan Bator 8
Amsterdam 7
Apia 7
Baghdad 7
Bamako 7
Belgrade 7
Bologna 7
Brasília 7
Brussels 7
Chennai 7
Totale 5.972
Salva come PNG Salva come JPEG
Nome #
Long-term effect of subthalamic and pallidal deep brain stimulation for status dystonicus in children with methylmalonic acidemia and GNAO1 mutation 193
De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions 135
Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown 131
Encephalopathies with intracranial calcification in children: Clinical and genetic characterization 130
A novel synonymous mutation in the MPZ gene causing an aberrant splicing pattern and Charcot-Marie-Tooth disease type 1b 130
A PDE10A de novo mutation causes childhood-onset chorea with diurnal fluctuations 127
Spasmodic dysphonia as a presenting symptom of spinocerebellar ataxia type 12 126
ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients 126
Inborn errors of coenzyme a metabolism and neurodegeneration 123
Cerebrospinal fluid biomarkers in progranulin mutations carriers 121
Recessive mutations in >VPS13D cause childhood onset movement disorders 120
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: potential relevance of antibody titers in monitoring treatment response 114
Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss. 114
Effect of Intensive Rehabilitation Program in Thermal Water on a Group of People with Parkinson’s Disease: A Retrospective Longitudinal Study 112
Expanding the genetics and phenotypic spectrum of Lysine-specific demethylase 5C (KDM5C): a report of 13 novel mutations 111
Adult diagnosis of Cockayne syndrome 111
Primary brain calcification: an international study reporting novel variants and associated phenotypes 109
ATP1A3-related disorders: An update 109
Restless Legs Syndrome in NKX2-1-related chorea: An expansion of the disease spectrum 108
A Missense Mutation in KCTD17 Causes Autosomal Dominant Myoclonus-Dystonia 108
Genetic mutations in Parkinson’s disease: screening of a selected population from North-Eastern Italy 107
CANS: Childhood acute neuropsychiatric syndromes 106
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 106
SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment 104
Peripheral nervous system involvement in Parkinson's disease: Evidence and controversies 103
Harmful iron-calcium relationship in pantothenate kinase associated neurodegeneration 102
C2orf37 mutational spectrum in Woodhouse-Sakati syndrome patients 102
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay 101
Complex movement disorders in primary antiphospholipid syndrome: A case report 101
Molecular Genetics of Niemann-Pick Type C Disease in Italy: An Update on 105 Patients and Description of 18 NPC1 Novel Variants 101
Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease 100
Emerging Monogenic Complex Hyperkinetic Disorders 100
Movement disorders in adult patients with classical galactosemia 99
Cerebellar and cortical hypometabolism in progressive stimulus-sensitive limb myoclonus in celiac disease 99
Diagnosis and treatment of pediatric onset isolated dystonia 97
Novel GNAL mutation with intra-familial clinical heterogeneity: Expanding the phenotype 96
EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia 96
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson's disease 95
Antiphospholipid-Related Chorea: Two Case Reports and Role of Metabolic Imaging 94
Corrigendum to “Restless legs syndrome in NKX2-1-related chorea: An expansion of the disease spectrum” (Brain and Development (2019) 41(3) (250–256), (S0387760418304959), (10.1016/j.braindev.2018.10.001)) 94
DYT2 screening in early-onset isolated dystonia 93
Movement disorders in adult surviving patients with maple syrup urine disease 92
High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology? 92
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusion 91
Partial loss-of-function of sodium channel SCN8A in familial isolated myoclonus 91
The syndrome of deafness-dystonia: Clinical and genetic heterogeneity 90
Cerebellar and cortical hypometabolism in progressive stimulus-sensitive limb myoclonus in celiac disease (Apr, 10.1007/s10072-021-05264-5, 2021) 90
Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay 89
Growth arrest specific 6 concentration is increased in the cerebrospinal fluid of patients with Alzheimer's disease 89
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease 89
Atypical Parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: Case report and literature review 89
Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: Beyond vascular damage 89
The clinical and genetic spectrum of primary familial brain calcification 89
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 88
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes 87
Frequency and phenotypic spectrum of KMT2B dystonia in childhood: A single-center cohort study 86
Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP 86
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline 85
Recent advances in genetics of chorea 84
MYORG-related disease is associated with central pontine calcifications and atypical parkinsonism 84
Paroxysmal Dyskinesias 84
Movement disorders in metabolic diseases in adulthood 83
The role of osteopontin in neurodegenerative diseases 82
A novel MRPS34 gene mutation with combined OXPHOS deficiency in an adult patient with Leigh syndrome 82
Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism 81
Early onset frontotemporal dementia with psychiatric presentation due to the C9ORF72 hexanucleotide repeat expansion: A case report 81
An adult patient with 3-methylglutaconic aciduria type 1 and movement disorders 81
Pallidal Deep Brain Stimulation in DYT6 Dystonia: Clinical Outcome and Predictive Factors for Motor Improvement 80
Teaching NeuroImages: Progressive asymmetric parkinsonism and tendon xanthomas 80
Levodopa-induced belly dancer's dyskinesias in Parkinson's disease: Report of one case 80
A case of childhood-onset dystonia-parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation 79
The relevance of gene panels in movement disorders diagnosis: A lab perspective 79
Phenotypic heterogeneity of the GRN Asp22fs mutation in a large italian kindred 78
Adult-onset KMT2B-related dystonia 77
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion (Journal of Neurology, (2022), 269, 10, (5606-5614), 10.1007/s00415-022-11269-7) 76
Rapidly progressive multiple system atrophy in a patient carrying LRRK2 G2019S mutation 75
Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort 75
Adult-Onset Focal Chorea in Fahr's Disease Resulting From SLC20A2 Mutation: A Novel Phenotype 74
Neurotransmitter and receptor systems in the subthalamic nucleus 73
Parkinson disease in Gaucher disease 72
The CACNA1B R1389H variant is not associated with myoclonus-dystonia in a large European multicentric cohort 71
Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: A reappraisal of genetic testing criteria 70
Progranulin Mutation Manifesting as Parkinson Disease: A Case Series from the PADUA-CESNE Cohort 69
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 68
Non-Motor Symptoms in Primary Familial Brain Calcification 67
Skin calcium deposits in primary familial brain calcification: A novel potential biomarker 66
GTP cyclohydrolase 1 mutations and Parkinson's disease: New insights beyond DOPA-responsive dystonia 63
NKX2.1 run-on mutation associated to familial brain-lung-thyroid syndrome 63
Scoping Review on ADCY5-Related Movement Disorders 62
Predicting cognitive decline in Parkinson's disease: Can we ask the genes? 62
Variants in ATP5F1B are associated with dominantly inherited dystonia 61
ANO3 as a Cause of Early-Onset Chorea Combined with Dystonia: Illustration of Phenotypic Evolution 57
Correction to: A case of childhood‑onset dystonia‑parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation 53
Functional and idiopathic cervical dystonia in two family members: A challenging diagnosis 52
Dominant VPS16 Pathogenic Variants: Not Only Isolated Dystonia 49
GPi-DBS for KMT2B-Associated Dystonia: Systematic Review and Meta-Analysis 48
Alpha‐synuclein RT‐QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients 47
Immunity and inflammation in neurodegenerative diseases 47
Reply to: "Heterogeneous Phenotypic Evolution in ANO3-Related Dystonia Due to the Recurrent p.Glu510Lys Variant" 45
Pediatric Onset of Generalized Dystonia, Cognitive Impairment, and Dysmorphic Features in a Patient Carrying Compound Heterozygous GNAL Mutations 45
Totale 8.971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.923
article - articoli 37.304
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 619
Totale 75.846
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021993 0 0 163 37 42 31 22 143 139 125 111 180
2021/20221.075 24 98 131 89 53 81 67 135 66 32 81 218
2022/2023581 136 57 25 38 85 57 3 56 74 4 31 15
2023/2024540 16 67 64 37 52 46 59 27 21 30 37 84
2024/20252.863 25 249 106 85 284 65 169 236 273 208 525 638
2025/20261.998 506 741 751 0 0 0 0 0 0 0 0 0
Totale 9.241